代谢物在舞蹈中:解读肠道微生物群介导的代谢重编程乳腺瘤微环境
Afaf Altrawy1, Maye M Khalifa1, Asmaa Abdelmaksoud2
1Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, Giza P. O. Box 77, Egypt.
Cancers
|January 8, 2025
概括
肠道微生物群影响乳腺癌 (BC) 的发展和治疗. 肠道细菌失衡或肠道细菌失衡与BC风险增加有关,并可能影响化疗的有效性,建议向微生物组的疗法.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 乳腺癌 (BC) 是全球女性的主要死亡原因.
- 新兴的研究表明,肠道微生物组与BC发育,进展和治疗反应有关.
- 肠道微生物群与乳腺瘤微环境相互作用,影响免疫力和新陈代谢.
研究的目的:
- 审查肠道微生物群和乳腺癌之间的复杂关系.
- 探索肠道微生物如何影响BC的免疫反应,炎症和代谢途径.
- 讨论微生物组向疗法的潜力,以预防和治疗BC.
主要方法:
- 对调查肠道微生物组和乳腺癌的研究进行文献综述.
- 对细菌物种,代谢物及其对BC的影响进行分析.
- 检查肠道微生物群对化疗疗效的影响.
主要成果:
- 特定的肠道细菌及其代谢物 (例如,SCFA,β-葡萄糖酶) 可以促进或抑制BC的进展.
- 肠道失调与BC的风险增加有关.
- 肠道微生物可以代谢化疗药物,可能降低治疗效率.
结论:
- 肠道微生物组在乳腺癌中起着至关重要的作用.
- 了解这些相互作用可能会导致新的治疗策略.
- 针对微生物组的治疗方法,如益生菌和便微生物群移植,对BC管理有希望.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


